Bioverativ (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bioverativ" in English language version.

refsWebsite

Global rank English rank

2web.archive.org

1^st place

1^st place

low place

low place

49^th place

47^th place

572^nd place

436^th place

1nridigital.com

low place

low place

1theguardian.com

12^th place

11^th place

1fiercepharma.com

low place

8,921^st place

1streetinsider.com

low place

low place

54^th place

48^th place

1bizjournals.com

407^th place

241^st place

1genengnews.com

low place

6,625^th place

biogen.com

media.biogen.com

"Biogen Announces Additional Members of Management Team of Hemophilia Spin-off Company Bioverativ - Biogen Media". Archived from the original on 2016-12-29. Retrieved 2016-12-28.
"Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company - Biogen Media". Archived from the original on 2016-08-13. Retrieved 2016-12-28.

bizjournals.com

"Coming soon to the Nasdaq: Biogen's hemophilia spinoff, Bioverativ - Boston Business Journal".

fiercepharma.com

"Amid takeover chatter, Biogen introduces hemophilia spinoff Bioverativ - FiercePharma". Fierce Pharma. 10 August 2016.

forbes.com

Cornell, Joe. "Biotech Giant Biogen To Spin-Off Bioverativ". Forbes.

genengnews.com

"Bioverativ to Acquire True North for up to $825M". 23 May 2017.

nridigital.com

"Sanofi Agrees to Buy Biovia for $11.6BN". Industry News. Pharma Technology Focus (67). Net Resources International. January 22, 2018.

reuters.com

D'Souza, Savio (May 3, 2016). "Biogen to spin off hemophilia drug business into a public company". Reuters. Retrieved May 3, 2016.
Hirschler, Ben; Kar-Gupta, Sudip; Erman, Michael (January 22, 2018). "Biotech M&A takes off as Sanofi and Celgene spend $20 billion". Reuters. Retrieved February 3, 2018.

sec.gov

"Biogen". SEC.gov. Retrieved 22 May 2024.

streetinsider.com

"Biogen (BIIB) Approves Separation of Bioverativ (BIVV); Declares Special Dividend".

theguardian.com

Farrell, Sean (January 2016). "Shire clinches $32bn takeover of Baxalta". The Guardian.

web.archive.org

"Biogen Announces Additional Members of Management Team of Hemophilia Spin-off Company Bioverativ - Biogen Media". Archived from the original on 2016-12-29. Retrieved 2016-12-28.
"Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company - Biogen Media". Archived from the original on 2016-08-13. Retrieved 2016-12-28.